Français

Contact Listing Owner






Your message has been sent!

Email All Listing Owners

Please fill in this form to send a message to all listing owners in your contact list.






Email My List To Me

Please fill in the following form to receive a copy of your contact list via email.




Print My List

My Selections

  • Your list is empty. You must add listings to your list before you can send an email.

Categories

Dentistry(15)
Medicine(666)
Nursing(52)
Pharmaceutical Sciences(29)
Public & Population Health(61)
Rehabilitation Sciences(36)
Social Science & Humanities(60)
Uncategorized(2)
Veterinary Medicine(28)

States/Provinces

Alberta(112)
Arizona(2)
British Columbia(121)
California(2)
DC(1)
Florida(1)
Manitoba(26)
New Jersey(1)
New York(1)
Newfoundland(7)
Nova Scotia(24)
Ontario(307)
Prince Edward Island(3)
Québec(181)
Saskatchewan(28)
Utah(1)

Alphabetical Search

Categorical Search

Full Search

Dean of Faculty of Science, York University

Rui Wang is one of the pioneers in the world who demonstrates that the hydrogen sulphide generated in our bodies plays a significant role in regulating body functions. Dr. Wang’s innovative and cutting-edge research on gasotransmitters including of carbon monoxide, nitric oxide and hydrogen sulphide, challenges many conventional modalities and doctrines on the regulation of body functions at all system levels. Dr. Wang continues to develop drug therapies that lower hypertension in an effort to improving the lifestyles of Canadians.

Dr Subodh Verma is an internationally renowned cardiac surgeon-scientist and the Canada Research Chair in Cardiovascular Surgery. He has held the Royal College of Physicians and Surgeons of Canada Gold Medal in Surgery and is a Royal Society of Canada College of New Scholars, Artists and Scientists appointee. He has had leadership roles in several paradigm-changing heart failure trials. He founded the St Michael’s CardioLink platform that originally focussed on cardiac surgery trials and now also studies cardiometabolic disease. He leads a dynamic pre-clinical and translational research team ...

Senior Scientist, University Health Network

Prof. Tymianski is a Senior Scientist at the Krembil Brain Institute. Among his scientific contributions is the discovery and development of PSD95 inhibitors for the treatment of stroke and related neurological disorders. His research spans from protein chemistry to global clinical trials. A lead compound, nerinetide, has completed Phase 3 trials and continues to be developed. Next generation compounds are also entering clinical studies. He is a retired neurosurgeon, having treated patients with complex cerebrovascular disorders, and leads NoNO Inc., a biotechnology company that sponsors the ...

Professeur, Centre hospitalier de l'Université de Montréal (CHUM)

Johanne Tremblay a contribué à la publication de plus de 210 articles dans le domaine de l’hypertension et à plusieurs brevets. Ses principales réalisations portent sur l’identification de nouveaux mécanismes moléculaires de contrôle de la pression artérielle. Elle a purifié et caractérisé un inhibiteur protéique de la tonine, une voie alternative de génération de l’angiotensine II et découvert la voie de signalisation du peptide natriurétique des oreillettes. Elle a découvert un activateur de la calmoduline et cloné et un nouveau gène surexprimé dans l’hypertension et impliqué dans la ...

Professor of Medicine, Montreal Heart Institute

Jean-Claude Tardif is presently the director of the research center at the Montreal Heart Institute, professor of medicine at the University of Montreal, and founder of the new University of Montreal Pharmacogenomics Centre. Dr. Tardif is a world leader in cardiovascular research and has made groundbreaking contributions to the fields of atherosclerosis and biomarkers to assess anti-atherosclerotic therapies. He has published 180 scientific articles in prestigious journals, written 25 book chapters, edited 2 books and given 280 lectures around the world. He holds the Pfizer and Canadian ...

George Steiner, Professor Emeritus of Medicine at the University of Toronto and former Head of Endocrinology at the Toronto General Hospital, has been devoted for over four decades to advancing knowledge about atherosclerosis in those afflicted with the global epidemic of diabetes. His world leadership role in basic and clinical research and his training of others was recognized by the WHO, which made him Head of their Collaborating Centre for the Study of Atherosclerosis in Diabetes. His basic work using sophisticated tracer methods led to an understanding of the way in which blood fat ...

Dr. David Spence, a clinician-scientist trained in Neurology, Internal Medicine and Clinical Pharmacology, has devoted his entire career to prevention of stroke. His clinical work has prevented an estimated 5,000 strokes, but his research, teaching and publications, by changing the way physicians approach stroke prevention, have prevented many more. He led many clinical trials of stroke prevention, including 4 major trials funded by NIH. He pioneered the understanding of pseudohypertension, co-discovered the effect of grapefruit on drug metabolism, pioneered the measurement of carotid ...

Leader mondial incontestable des "Proprotéines Convertases", ayant cloné sept des neuf Convertases, Nabil G. Seidah démontre leurs implications dans plusieurs pathologies humaines, notamment le rôle de PCSK9 dans l'hypercholestérolémie familiale. Il est à l'origine du médicament le plus efficace à ce jour pour réduire le LDL-cholestérol sanguin. Il est auteur de plus de 760 publications et a prononcé 470 conférences dans 30 pays. Ses découvertes majeures font partie des manuels de biochimie et de médecine. Passionné par la découverte, il a formé une relève de 150 étudiants/chercheurs. Son ...

Ernesto Schiffrin has made seminal contributions to our understanding of the mechanisms leading and contributing to hypertension. He has delineated the role that hormones such as angiotensin, aldosterone and endothelin play in the regulation of the vasculature in hypertension. He characterized arteries involved in blood pressure elevation in patients with hypertension, and effects of treatment on their blood vessels, contributing to improving outcome for hypertensive patients. He is past President of the Canadian Hypertension Society and Chair of the High Blood Pressure Research Council of ...

Prof. School of Kinesiology & Health Studies, Queen's University

Dr. Robert Ross obtained a PhD in Exercise Physiology from the Université de Montréal in 1992. He is currently a Professor within the School of Kinesiology and Health Studies at Queen's University. His research program focuses on the development of strategies designed to manage lifestyle-based disease. He is a Past-President of the Canadian Society for Exercise Physiology, and Vice-President of the College of Kinesiology in Ontario. He is a Fellow of the American College of Sports Medicine, the American Heart Association, and is a recipient of the Honor Award from the Canadian Society of ...